Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011)

被引：10

作者：

Schaumburg, F. ^{[1
]}

Idelevich, E. A. ^{[1
]}

Peters, G. ^{[1
]}

Mellmann, A. ^{[2
]}

von Eiff, C. ^{[1
,3
]}

Becker, K. ^{[1
]}

机构：

[1] Univ Hosp Munster, Inst Med Microbiol, D-48149 Munster, Germany

[2] Univ Hosp Munster, Inst Hyg, D-48149 Munster, Germany

[3] Pfizer Pharma GmbH, Berlin, Germany

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2014年 / 20卷 / 09期

关键词：

Genotype; Germany; LA-MRSA; methicillin-resistant Staphylococcus aureus; resistance; MRSA; LIVESTOCK;

D O I：

10.1111/1469-0691.12519

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004-2005 and 2010-2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim-sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid.

引用

页码：O554 / O557

页数：4

共 50 条

[41] Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus
Monnet, DL
Frimodt-Moller, N
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) : 161 - 163
[42] Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus
Fitch, L
Johnson, AP
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) : 578 - 578
[43] Trends in antimicrobial susceptibility patterns in healthcare-associated methicillin-resistant Staphylococcus aureus from bloodstream infections: A joinpoint regression analysis
Nii, Diana Mayumi
Martins, Maria Aparecida Vitagliano
Fortaleza, Carlos Magno Castelo Branco
INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2022, 43 (12) : 1955 - 1957
[44] NON-SUSCEPTIBILITY TRENDS AMONG METHICILLIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI ISOLATED FROM BLOOD CULTURES
Povazan, Anika
Vukelic, Anka
Kurucin, Tatjana
Hadnadev, Mirjana
Milosevic, Vesna
Gusman, Vera
ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (01) : 79 - 86
[45] Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals
Crowcroft, NS
Ronveaux, O
Monnet, DL
Mertens, R
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (01): : 31 - 36
[46] Restoring susceptibility to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus
Nguyen, Van T.
Birhanu, Biruk T.
Miguel-Ruano, Vega
Kim, Choon
Batuecas, Mayte
Yang, Jingdong
El-Araby, Amr M.
Jimenez-Faraco, Eva
Schroeder, Valerie A.
Alba, Alejandra
Rana, Neha
Sader, Safaa
Thomas, Caitlyn A.
Feltzer, Rhona
Lee, Mijoon
Fisher, Jed F.
Hermoso, Juan A.
Chang, Mayland
Mobashery, Shahriar
NATURE CHEMICAL BIOLOGY, 2024, : 482 - 489
[47] Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages
Howe, RA
Monk, A
Wootton, M
Walsh, TR
Enright, MC
EMERGING INFECTIOUS DISEASES, 2004, 10 (05) : 855 - 857
[48] In Vitro Susceptibility of Chloramphenicol Against Methicillin-Resistant Staphylococcus aureus
Fayyaz, Muhammad
Mirza, Irfan Ali
Ahmed, Zaheer
Abbasi, Shahid Ahmad
Hussain, Aamir
Ali, Shamshad
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (09): : 637 - 640
[49] Methicillin-resistant Staphylococcus aureus:: clinical manifestations and antimicrobial therapy
Cunha, BA
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 : 33 - 42
[50] Jatrorrhizine suppresses the antimicrobial resistance of methicillin-resistant Staphylococcus aureus
Yu, Haiming
Wang, Yuefei
Wang, Xiaoqing
Guo, Junjie
Wang, Hui
Zhang, Hao
Du, Fengxia
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3715 - 3722

← 1 2 3 4 5 →